CPNI Bulletin - Neuromuscular Edition
Message from Brian T. Andrews, M.D., FACS
When a physician brings to mind the diagnosis of ALS, or Lou Gehrig’s disease, the first mental images are probably those of a near-helpless and disabled Stephen Hawking, immobile for years in his motorized wheelchair. In truth there is an extremely active world research effort ongoing into the genetics and mechanisms of the disease, clinical trials, and the multidisciplinary case management that can prolong useful life. It happens that at California Pacific Medical Center we have the Forbes Norris MDA/ALS Research and Treatment Center, one of the premier programs in the world focused upon both this research, basic and clinical, and management of such patients.
In this issue of CPNI Bulletin we focus on our Neuromuscular Diseases Program, including ALS, myasthenia gravis, myopathy, neuropathy, and electrodiagnosis. This subspecialty has been a long-standing presence at CPMC, indeed beginning many years ago at the Children’s Hospital of San Francisco (now the California Campus). The program enjoys a well-deserved international reputation, and cares for patients throughout the western United States. I applaud the efforts of researchers, nurses, case managers, and neurologists integral to this program. I hope that you enjoy this issue of CPNI Bulletin.
BRIAN T. ANDREWS, M.D., FACS
Chairman, Department of Neurosciences